The Minnesota Partnership is a collaboration of the state, the University of Minnesota, and Mayo Clinic.
The goal is to position Minnesota as a world leader in biotechnology that will result in:
- important new medical discoveries
- improved health care for patients
- development of new business and jobs in Minnesota
Research teams with investigators from both institutions are studying: Alzheimer's disease, several types of cancer and cancer drug development, heart disease, obesity, infectious diseases, muscle diseases, nanotechnology, and addiction.
- Researchers have published 94 peer-reviewed papers in scientific journals. Partnership researchers have also made more than 100 presentations worldwide.
- More than $100 million in external funding from National Institutes of Health, donors, and industry
- For every $1 million in funding, nearly 16 jobs are created for the state of Minnesota.
- 3 patents, 1 formal licensing application and 1 project transitioning to commercialization.
- Awarded funding for 45 research projects and 14 competitive infrastructure improvement projects